Aerie pharmaceuticals to participate in the oppenheimer 31st annual virtual healthcare conference

Durham, n.c.--(business wire)--aerie pharmaceuticals, inc. (nasdaq: aeri), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced that richard j. rubino, chief financial officer, will present in a fireside discussion at the oppenheimer 31st annual virtual healthcare conference on wednesday, march 17, 2021 at 8
AERI Ratings Summary
AERI Quant Ranking